News and Trends 9 Apr 2020
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in patients with Alzheimer’s disease and…
Neurological disorders
- Latest Posts
News and Trends 24 Mar 2020
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in…
News and Trends 11 Mar 2020
Phase III Fail for MedDay’s Multiple Sclerosis Treatment
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms of multiple sclerosis in a…
News and Trends 27 Feb 2020
Scientists Connect Brain Cells to Machines Over the Internet
An international group of researchers has set up a brain-machine interface between cultured nerve cells and electronic chips linked over…
ADVERTISEMENT
News and Trends 7 Feb 2020
EU Project Set up to Fight Alzheimer’s Disease with Lasers
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s and Huntington’s disease by making…
News and Trends 4 Feb 2020
Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI for the treatment of autism…
In Depth 9 Dec 2019
As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?
With big pharma exiting the neurology space in droves, biotech innovation might be the key to bring about a much-needed…
News and Trends 5 Sep 2019
Orchard’s Gene Therapy Improves Children’s Motor Ability
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than six times over the target…
Startup Scout 31 May 2019
This Biotech Treats a Neurological Autoimmune Disorder Using DNA
We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing DNA molecules that could treat…
News and Trends 28 Mar 2019
Swiss Biotech Raises €20M to Develop Decoy Drugs in Autoimmune Disease
The biotech Polyneuron has raised a Series A round of €20.1M (CHF 22.5M) to start human testing with a treatment…
14 May 2018
Brain Metabolomics: A New Angle on Neurodegenerative Disorders
Neurodegenerative disorders, such as Alzheimer’s disease and multiple sclerosis (MS), are notoriously difficult to treat mainly because, despite decades of…
News and Trends 21 Feb 2018
Early Autism Diagnosis Could be Possible With New Blood and Urine Tests
The detection of damaged proteins in blood and urine tests could help to diagnose autism quicker so that children can…
Interview 9 Nov 2017
Meet the Spin-Out Queen Taking on Neurological Diseases
Mary Kerr, CEO of NeRRe and Managing Director of KanDy, told us how its approaches could change the face of…
News and Trends 30 Oct 2017
French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s
Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy,…
More News! 14 Sep 2017
New Dutch Spin Out will Treat Stroke with RNA Therapy
ProQR has spun out Amylon Therapeutics, a company that will treat central nervous system disorders with a lead candidate based…
In Depth 6 Jun 2017
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great, and which biotechs are gunning…
ADVERTISEMENT
News and Trends 2 Jun 2017
Austrian Researchers build an improved Mini-Brain to support Psychiatry
Researchers from Austria and the UK have made new advances in engineering brain-like structures. These lab-grown organoids mimic important functions…
News and Trends 26 May 2017
UPDATE: UK Cannabis Biotech ready for a Blockbuster in Rare Epilepsy
UPDATE (26/05/2017): GW has released more positive results in The New England Journal of Medicine demonstrating that Epidiolex dramatically reduces convulsive…
News and Trends 18 May 2017
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be used to treat migraine headaches.…
News and Trends 12 May 2017
UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its partner, Zambon, which has the…
